Barbieri J - Search Results

1

FDA Reports of Alopecia as an Adverse Event to Isotretinoin.

Tkachenko E, Singer SB, Sharma P, Barbieri J, Mostaghimi A. Tkachenko E, et al. Among authors: barbieri j. J Cutan Med Surg. 2019 Jul/Aug;23(4):451-452. doi: 10.1177/1203475419838553. J Cutan Med Surg. 2019. PMID: 31337236 No abstract available.

2

Impact of Industry Payments on Prescribing Patterns for Tumor Necrosis Factor Inhibitors Among Medicare Beneficiaries.

Singh P, Forman H, Adamson AS, Mostaghimi A, Ogdie AR, Oganisian A, Barbieri JS. Singh P, et al. J Gen Intern Med. 2019 Feb;34(2):176-178. doi: 10.1007/s11606-018-4698-x. J Gen Intern Med. 2019. PMID: 30324292 Free PMC article. No abstract available.

3

Evaluation of Clinical Compendia Used for Medicare Part D Coverage Determinations for Off-label Prescribing in Dermatology.

Barbieri JS, St Claire K, Mostaghimi A, Albrecht J. Barbieri JS, et al. JAMA Dermatol. 2019 Mar 1;155(3):315-320. doi: 10.1001/jamadermatol.2018.5052. JAMA Dermatol. 2019. PMID: 30673082 Free PMC article.

4

Psychiatric Adverse Events in Patients Taking Isotretinoin as Reported in a Food and Drug Administration Database From 1997 to 2017.

Singer S, Tkachenko E, Sharma P, Barbieri JS, Mostaghimi A. Singer S, et al. JAMA Dermatol. 2019 Oct 1;155(10):1162-1166. doi: 10.1001/jamadermatol.2019.1416. JAMA Dermatol. 2019. PMID: 31268488 Free PMC article.

5

US Food and Drug Administration Reports of Pregnancy and Pregnancy-Related Adverse Events Associated With Isotretinoin.

Tkachenko E, Singer S, Sharma P, Barbieri J, Mostaghimi A. Tkachenko E, et al. Among authors: barbieri j. JAMA Dermatol. 2019 Oct 1;155(10):1175-1179. doi: 10.1001/jamadermatol.2019.1388. JAMA Dermatol. 2019. PMID: 31314041 Free PMC article.

6

A State-of-the-Art Review Highlighting Medical Overuse in Dermatology, 2017-2018: A Systematic Review.

Pournamdari AB, Tkachenko E, Barbieri J, Adamson AS, Mostaghimi A. Pournamdari AB, et al. Among authors: barbieri j. JAMA Dermatol. 2019 Dec 1;155(12):1410-1415. doi: 10.1001/jamadermatol.2019.3064. JAMA Dermatol. 2019. PMID: 31642872

7

Antibiotic utilization in Medicare beneficiaries receiving Mohs micrographic surgery.

Singh P, Mostaghimi A, Barbieri JS. Singh P, et al. J Am Acad Dermatol. 2020 Oct;83(4):1184-1186. doi: 10.1016/j.jaad.2020.02.021. Epub 2020 Feb 14. J Am Acad Dermatol. 2020. PMID: 32068038 Free PMC article. No abstract available.

8

Simplifying contraception requirements for iPLEDGE: A decision analysis.

Barbieri JS, Roe AH, Mostaghimi A. Barbieri JS, et al. J Am Acad Dermatol. 2020 Jul;83(1):104-108. doi: 10.1016/j.jaad.2020.02.022. Epub 2020 Feb 14. J Am Acad Dermatol. 2020. PMID: 32068040 Free PMC article.

9

Patient Perspectives on the Use of Artificial Intelligence for Skin Cancer Screening: A Qualitative Study.

Nelson CA, Pérez-Chada LM, Creadore A, Li SJ, Lo K, Manjaly P, Pournamdari AB, Tkachenko E, Barbieri JS, Ko JM, Menon AV, Hartman RI, Mostaghimi A. Nelson CA, et al. JAMA Dermatol. 2020 May 1;156(5):501-512. doi: 10.1001/jamadermatol.2019.5014. JAMA Dermatol. 2020. PMID: 32159733 Free PMC article.

10

Influence of Contraception Class on Incidence and Severity of Acne Vulgaris.

Barbieri JS, Mitra N, Margolis DJ, Harper CC, Mostaghimi A, Abuabara K. Barbieri JS, et al. Obstet Gynecol. 2020 Jun;135(6):1306-1312. doi: 10.1097/AOG.0000000000003880. Obstet Gynecol. 2020. PMID: 32459422 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

428 results

Search Page

Filters